c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

N. Zilembo; L. Mariani; A. Martinetti; R. Miceli; E. Seregni; E. Bichisao; I. La Torre; P. Pozzi; L. Ferrari; D. De Candis; V.R. Longarini; E. Bajetta; E. Bombardieri

doi:10.1054/brst.2002.0416

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

The Breast ◽

10.1054/brst.2002.0416 ◽

2002 ◽

Vol 11 (4) ◽

pp. 286-294

Author(s):

N. Zilembo ◽

L. Mariani ◽

A. Martinetti ◽

R. Miceli ◽

E. Seregni ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Serum Level ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients

Download Full-text

Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients

Breast Cancer Research ◽

10.1186/bcr1760 ◽

2007 ◽

Vol 9 (4) ◽

Cited By ~ 56

Author(s):

Javier Silva ◽

Vanesa García ◽

José M García ◽

Cristina Peña ◽

Gemma Domínguez ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients

Download Full-text

Poor Marital Quality Affects Psychological Distress and Immunity in Advanced Breast Cancer Patients

PsycEXTRA Dataset ◽

10.1037/e582332013-001 ◽

2013 ◽

Author(s):

Tammy A. Schuler ◽

Barbara L. Andersen

Keyword(s):

Breast Cancer ◽

Psychological Distress ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Marital Quality ◽

Advanced Breast ◽

Breast Cancer Patients

Download Full-text

SERAPHINA – Safety, Efficacy and patient Reported outcomes of Advanced breast cancer Patients: tHerapy management wIth NAb-paclitaxel in daily routine (a non-interventional study)

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-0036-1592816 ◽

2016 ◽

Vol 76 (10) ◽

Author(s):

PA Fasching ◽

MP Lux ◽

L Häberle ◽

M Wallwiener ◽

A Schneeweiss ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Patient Reported Outcomes ◽

Advanced Breast ◽

Daily Routine ◽

Breast Cancer Patients ◽

Interventional Study ◽

Therapy Management ◽

Patient Reported

Download Full-text

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Case Medical Research ◽

10.31525/ct1-nct03913234 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Phase Ib

Download Full-text

Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis

Case Medical Research ◽

10.31525/ct1-nct04132960 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Antibody Drug Conjugate ◽

Drug Conjugate ◽

Antibody Drug

Download Full-text

PP-8-4 An open, comparative randomized trial comparing formestane vs oral megestrol acetate as a second-line therapy in postmenopausal advanced breast cancer patients

European Journal of Cancer ◽

10.1016/0959-8049(96)84239-0 ◽

1996 ◽

Vol 32 ◽

pp. 49 ◽

Cited By ~ 5

Author(s):

C. Rose ◽

M. Freue ◽

M. Kjaer ◽

C. Boni ◽

F. Jänicke ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Cancer Patients ◽

Advanced Breast ◽

Megestrol Acetate ◽

Second Line ◽

Breast Cancer Patients ◽

Second Line Therapy ◽

Line Therapy

Download Full-text

A real-life study on everolimus plus exemestane therapy in a cohort of HR-positive, HER2-negative postmenopausal advanced breast cancer patients; A study of the SOutheast Netherlands Advanced BREast cancer (SONABRE) Registry

European Journal of Cancer ◽

10.1016/s0959-8049(18)30564-1 ◽

2018 ◽

Vol 92 ◽

pp. S113

Author(s):

L.M. Knapen ◽

S.M.E. Geurts ◽

M. De Boer ◽

S. Croes ◽

K.I.E. Ibragimova ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Real Life ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Life Study ◽

Real Life Study

Download Full-text

0184 Clinical experience with fulvestrant, pure oestrogen receptor (ER) antagonist with no agonist effects, in pre-treated advanced breast cancer patients

The Breast ◽

10.1016/s0960-9776(09)70207-3 ◽

2009 ◽

Vol 18 ◽

pp. S65

Author(s):

S.S.M. Menjón ◽

J.J.G. Garcia ◽

E.E.G. Gonzalez

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Clinical Experience ◽

Oestrogen Receptor ◽

Advanced Breast ◽

Breast Cancer Patients

Download Full-text

Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents

World Journal of Surgical Oncology ◽

10.1186/1477-7819-4-44 ◽

2006 ◽

Vol 4 (1) ◽

Cited By ~ 10

Author(s):

Amit Agrawal ◽

John F R Robertson ◽

K L Cheung

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

High Dose ◽

Breast Cancer Patients ◽

Post Menopausal

Download Full-text

In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.2010.04167.x ◽

2010 ◽

pp. no-no ◽

Cited By ~ 52

Author(s):

S. Meraviglia ◽

M. Eberl ◽

D. Vermijlen ◽

M. Todaro ◽

S. Buccheri ◽

...

Keyword(s):

Breast Cancer ◽

T Cells ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Low Dose ◽

Interleukin 2 ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Vγ9vδ2 T Cells

Download Full-text